168 related articles for article (PubMed ID: 37105339)
1. Methodological shortcomings of preclinical research on chemotherapy-induced cognitive impairment.
Ossorio-Salazar VA; D'Hooge R
Neurosci Biobehav Rev; 2023 Jul; 150():105198. PubMed ID: 37105339
[No Abstract] [Full Text] [Related]
2. The effectiveness of anti-inflammatory agents in reducing chemotherapy-induced cognitive impairment in preclinical models - A systematic review.
Haller OJ; Semendric I; George RP; Collins-Praino LE; Whittaker AL
Neurosci Biobehav Rev; 2023 May; 148():105120. PubMed ID: 36906244
[TBL] [Abstract][Full Text] [Related]
3. Neuroimmune reactivity marker expression in rodent models of chemotherapy-induced cognitive impairment: A systematic scoping review.
George RP; Semendric I; Hutchinson MR; Whittaker AL
Brain Behav Immun; 2021 May; 94():392-409. PubMed ID: 33516919
[TBL] [Abstract][Full Text] [Related]
4. An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants.
Das A; Ranadive N; Kinra M; Nampoothiri M; Arora D; Mudgal J
Curr Neuropharmacol; 2020; 18(9):838-851. PubMed ID: 32091339
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-Induced Cognitive Impairment.
Kinsley K; Pritchett W
Clin J Oncol Nurs; 2023 Mar; 27(2):205-208. PubMed ID: 37677835
[TBL] [Abstract][Full Text] [Related]
6. A Review on the Neuroprotective Effect of Berberine against Chemotherapy- induced Cognitive Impairment.
Sahu K; Singh S; Devi B; Singh C; Singh A
Curr Drug Targets; 2022; 23(9):913-923. PubMed ID: 35240956
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of cytokine mediated chemotherapy induced cognitive impairment.
Ren X; St Clair DK; Butterfield DA
Pharmacol Res; 2017 Mar; 117():267-273. PubMed ID: 28063894
[TBL] [Abstract][Full Text] [Related]
8. Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events.
Dias-Carvalho A; Ferreira M; Ferreira R; Bastos ML; Sá SI; Capela JP; Carvalho F; Costa VM
Arch Toxicol; 2022 Jan; 96(1):11-78. PubMed ID: 34725718
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-induced cognitive impairment (CICI): An overview of etiology and pathogenesis.
Mounier NM; Abdel-Maged AE; Wahdan SA; Gad AM; Azab SS
Life Sci; 2020 Oct; 258():118071. PubMed ID: 32673664
[TBL] [Abstract][Full Text] [Related]
10. [Chemobrain - cognitive disorders after chemotherapy].
Kupryjaniuk A; Sobstyl M
Pol Merkur Lekarski; 2022 Dec; 50(300):398-400. PubMed ID: 36645690
[TBL] [Abstract][Full Text] [Related]
11. Animal models of chemotherapy-induced cognitive decline in preclinical drug development.
John J; Kinra M; Mudgal J; Viswanatha GL; Nandakumar K
Psychopharmacology (Berl); 2021 Nov; 238(11):3025-3053. PubMed ID: 34643772
[TBL] [Abstract][Full Text] [Related]
12. The microbiota-gut-brain axis: An emerging therapeutic target in chemotherapy-induced cognitive impairment.
Subramaniam CB; Bowen JM; Gladman MA; Lustberg MB; Mayo SJ; Wardill HR
Neurosci Biobehav Rev; 2020 Sep; 116():470-479. PubMed ID: 32681936
[TBL] [Abstract][Full Text] [Related]
13. Perioperative considerations in patients with chemotherapy-induced cognitive impairment: a narrative review.
Guran E; Hu J; Wefel JS; Chung C; Cata JP
Br J Anaesth; 2022 Dec; 129(6):909-922. PubMed ID: 36270848
[TBL] [Abstract][Full Text] [Related]
14. The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.
Butterfield DA
Free Radic Biol Med; 2014 Sep; 74():157-74. PubMed ID: 24996204
[TBL] [Abstract][Full Text] [Related]
15. Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment ("chemobrain"), a condition that significantly impairs the quality of life of many cancer survivors.
Ren X; Boriero D; Chaiswing L; Bondada S; St Clair DK; Butterfield DA
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1088-1097. PubMed ID: 30759363
[TBL] [Abstract][Full Text] [Related]
16. Oroxylum Indicum ameliorates chemotherapy induced cognitive impairment.
Pondugula SR; Majrashi M; Almaghrabi M; Ramesh S; Abbott KL; Govindarajulu M; Gill K; Fahoury E; Narayanan N; Desai D; Ren J; Nadar R; McElroy T; Moore T; Majeed M; Kalyanam N; Dhanasekaran M
PLoS One; 2021; 16(6):e0252522. PubMed ID: 34081735
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of NLRP3 alleviated chemotherapy-induced cognitive impairment in rats.
Jia L; Zhou Y; Ma L; Li W; Chan C; Zhang S; Zhao Y
Neurosci Lett; 2023 Jan; 793():136975. PubMed ID: 36427814
[TBL] [Abstract][Full Text] [Related]
18. Melatonin and metformin counteract cognitive dysfunction equally in male rats with doxorubicin-induced chemobrain.
Chunchai T; Pintana H; Arinno A; Ongnok B; Pantiya P; Khuanjing T; Prathumsap N; Maneechote C; Chattipakorn N; Chattipakorn SC
Neurotoxicology; 2023 Jan; 94():158-171. PubMed ID: 36463981
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions.
Ongnok B; Chattipakorn N; Chattipakorn SC
Exp Neurol; 2020 Feb; 324():113118. PubMed ID: 31756316
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-induced cognitive impairment: focus on the intersection of oxidative stress and TNFα.
Rummel NG; Chaiswing L; Bondada S; St Clair DK; Butterfield DA
Cell Mol Life Sci; 2021 Oct; 78(19-20):6533-6540. PubMed ID: 34424346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
